Skip to content ↓

In the Media

Displaying 15 news clips on page 3

Vogue

Vogue editor Lisa Wong Macabasco spotlights “Lighten Up! On Biology and Time,” a new exhibit at the MIT Museum that “traces the rhythms of life itself: circadian patterns, light’s command over the body, and the delicate architecture of alertness and rest.” The exhibit features “18 works that blend science and art, from immersive soundscapes to visualizations of circadian patterns and reflective spaces where you observe your own heartbeat and alertness in new ways,” explains Macabasco. 

Newsweek

Researchers at MIT have developed “mini livers” that “can be injected into the body to help take over the functions of a failing liver,” reports Ian Randall for Newsweek. “If realized clinically, the development could provide a lifeline for many of the more than 10,000 Americans with chronic liver disease currently waiting for a transplant,” writes Randall. 

Smithsonian Magazine

Prof. Sara Beery speaks with Smithsonian Magazine reporter Mike Bock about the benefits of AI use in ecological research. “There’s an increasing need to build strong machine learning skills directly in the ecological community,” says Beery. “These students don’t need to be AI researchers. But they do need access to the skills to apply these techniques to their research problems.” 

Times Higher Education

Times Higher Education features President Sally Kornbluth among the world’s top 10 universities led by women in 2026, reports Patrick Jack for Times Higher Education. “Of the top 200 institutions in the Times Higher Education World University Rankings 2026, 58 have a female vice-chancellor or president – 29 per cent of the total,” writes Jack. 

WBUR

Prof. Alessandro Acquisti speaks with WBUR reporters Woodrow Hartzog and Neil Richards about privacy concerns surrounding consumer data. “The online advertising industry has long extolled the benefits of targeted advertising, presenting it as an economic win-win for publishers, merchants and consumers alike,” says Acquisti. “And yet, in reality, there is little robust empirical evidence that any stakeholder – other than the data intermediaries themselves – actually benefit from this type of advertising.” 

Associated Press

Postdoctoral Fellow Florian Galleri speaks with Associated Press reporter Sylvie Corbet about France’s move to align “its nuclear deterrent strategy more closely with European allies while keeping full control over any strike decision.” Galleri says “the strategic backing intended to integrate French nuclear deterrence into a collective European defense framework necessarily requires a degree of coordination and joint planning.” 

CNBC

A study by Prof. Taha Choukhmane and his colleagues has found that “by switching retirement contributions to the account with the higher match rate, 1 in 5 couples could increase their savings by an estimated $750 per year,” reports Lorie Konish for CNBC. “The absence of coordination can be a choice, but it’s a costly choice,” says Choukhmane. 

Fortune

Prof. Sherry Turkle speaks with Fortune reporter Jacqueline Munis about the risks of using generative AI to address human emotions, such as grief. 

State House News

The Advanced Research Projects Agency for Health (ARPA-H) is providing funding for the Ocular Laboratory for Analysis of Biomarkers (OCULAB), which includes researchers from MIT and "will initially focus on dry eye disease that affects more than 20 million people in the United States,” reports Alison Kuznitz at State House News Service. The MIT team is "building sensors to detect biomarkers of dry eye disease and diabetes,” writes Kuznitz. 

WBUR

Senior Research Associate Jim Walsh speaks with WBUR Here & Now host Indria Lakshmanan about the U.S. military action in Iran. 

Interesting Engineering

MIT researchers have “achieved a breakthrough towards building scalable quantum computers,” reports Prabhat Ranjan Mishra for Interesting Engineering, using “cryoelectronics to control ion traps, a key step toward realizing scalable quantum computers.”  The team says “this proof-of-principle experiment marks an important advancement toward building large-scale ion-trap quantum computing systems,” writes Mishra.

CNBC

Prof. Danielle Wood speaks with CNBC reporter Laya Neelakandan about NASA’s Artemis III, the United States’ first venture back to the moon in over 50 years, which will carry the first female and first Black astronaut to the Moon. “NASA’s been thinking through this whole process, two decades’ worth, of what we’re going to do is prepare the government to focus on these harder, next-generation missions and be able to do things that are not already demonstrated,” says Wood. 

USA Today

Research Scientist Judah Cohen speaks with USA Today reporter Doyle Rice about how changes in the polar vortex will impact March weather across the United States. “I would expect a milder period in the eastern US until close to the spring equinox," says Cohen. "Then I think eventually colder weather arrives to the eastern U.S. related to the polar vortex split in late March or early April that could hang around for a while."

The Boston Globe

In an opinion piece for The Boston Globe, MIT Prof. Carlo Ratti and University of Toronto Prof. Richard Florida explore the “paradox of overtourism.” Ratti and Florida note that: “Tourism accelerates global convergence — the same luxury retailers, hotel chains, and Instagram‑ready design cues that push cities to conform to international expectations. At times, it can even undermine more authentic local businesses, which cannot compete against much larger global competitors. Yet local distinctiveness does not vanish under global pressure; it adapts. The visual signatures that make one place different from another persist beneath the surface layer of brands. That is where efforts to manage tourism’s cultural impact should concentrate.” 

Boston.com

Prof. Robert Langer, Prof. Giovanni Traverso and former postdoctoral fellow Thomas von Erlach founded Vivtex, a biotechnology startup that has “created a high-tech system called a ‘GI tract on a chip’ that uses robotics and AI to test how drugs move through the human digestive system,” reports Beth Treffeisen for Boston.com. “The technology allows Vivtex to quickly test thousands of drug formulations and predict how they will be absorbed in people, much more accurately than traditional lab methods.”